---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-171014"
form_type: "8-K"
ticker: "AMLX"
cik: "0001658551"
company_name: "Amylyx Pharmaceuticals, Inc."
filed_at: "2022-06-09T23:59:59+00:00"
generated_at: "2026-06-25T03:11:50.018531+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Amylyx shareholders elect Class I directors and ratify Deloitte as auditor at 2022 annual meeting

## Summary
- Justin Klee elected Class I director with 42,100,898 votes for, 1,607,476 withheld.
- Isaac Cheng elected Class I director with 41,946,619 votes for, 1,761,755 withheld.
- Ratification of Deloitte & Touche as independent auditor for FY2022 approved with 43,834,729 votes for, 72,090 against.

## SEC filing metadata
- accession: 0001193125-22-171014
- form_type: 8-K
- ticker: AMLX
- cik: 0001658551
- company_name: Amylyx Pharmaceuticals, Inc.
- filed_at: 2022-06-09T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1658551/000119312522171014/0001193125-22-171014-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1658551/000119312522171014/d362452d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-171014
- JSON: https://secwatch.observer/filing/0001193125-22-171014.json
- Plain text: https://secwatch.observer/filing/0001193125-22-171014.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.